Indeed, with the exception of RCC, tumor patients treated with ICPis and/or cancer vaccines have an increased response to treatment and a prolonged survival if they have a pre-existing local CD8+ T cell infiltration of the tumor (39, 40). This evidence concerns the gene CD8A and neoplasm.